Hybrid Service Model
ImmunoPrecise is an innovation-driven technology platform company with a distinctive end-to-end service model, designed to reduce time and risk with custom applications. We support our business partners in the quest to discover and develop novel antibodies against a broad range of classes of disease targets in “one-stop”, with:
- An unrivaled suite of services
- Target design and antigen modeling
- A broad range of immunization technologies in a multitude of species and strains
- Best-in-class hybridoma, B-cell, and phage display antibody discovery platforms
- Antibody characterization, engineering, and manufacturing services